You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 4, 2024

Details for New Drug Application (NDA): 210583


✉ Email this page to a colleague

« Back to Dashboard


NDA 210583 describes ANJESO, which is a drug marketed by Baudax and is included in one NDA. There are seven patents protecting this drug. Additional details are available on the ANJESO profile page.

The generic ingredient in ANJESO is meloxicam. There are twenty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
Summary for 210583
Tradename:ANJESO
Applicant:Baudax
Ingredient:meloxicam
Patents:7
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INTRAVENOUSStrength30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Feb 20, 2020TE:RLD:Yes
Regulatory Exclusivity Expiration:Feb 20, 2023
Regulatory Exclusivity Use:NEW PRODUCT
Patent:⤷  Try a TrialPatent Expiration:Feb 24, 2024Product Flag?YSubstance Flag?Delist Request?
Patented Use:MANAGEMENT OF MODERATE-TO-SEVERE PAIN BY INTRAVENOUS INJECTION
Patent:⤷  Try a TrialPatent Expiration:Feb 24, 2024Product Flag?YSubstance Flag?Delist Request?
Patented Use:MANAGEMENT OF MODERATE-TO-SEVERE PAIN BY INTRAVENOUS INJECTION

Expired US Patents for NDA 210583

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baudax ANJESO meloxicam SOLUTION;INTRAVENOUS 210583-001 Feb 20, 2020 ⤷  Try a Trial ⤷  Try a Trial
Baudax ANJESO meloxicam SOLUTION;INTRAVENOUS 210583-001 Feb 20, 2020 ⤷  Try a Trial ⤷  Try a Trial
Baudax ANJESO meloxicam SOLUTION;INTRAVENOUS 210583-001 Feb 20, 2020 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.